Spotlight
Innovation Spotlight: Advanced AAV Capsid Analysis
AAV
Capsid
Cell Therapy
Gene Therapy
Cell & Gene Analytics
Analytical Excellence for Cell & Gene Therapy Products
ProtaGene is a CRO leading the industry in developing DNA/RNA and protein vector analytics, advancing gene therapy safety, gene expression analysis, integration site analysis, genetic analytics, and related bioinformatic solutions.
Talk to Our Team to Get Started
We’re well-staffed and positioned to support your most complex cell and gene therapy programs.
"*" indicates required fields
Industry-leading Expertise Advancing Gene Therapy Safety
We have been at the forefront of developing DNA/RNA and
protein analytics that advance gene therapy safety.
Diverse Cell and Gene Therapeutic Platform Expertise
-
Capsid-based Vectors
- AAVs (Multiple Serotypes and Engineered Vectors)
- Novel Systems
- Adenovirus
-
Complex, Envelope Vectors
- Lentivirus
- Gammaretrovirus
- Novel Viruses
-
Non-viral Vectors
- Polynucleotide (DNA/RNA) Formulations
- Lipid Nanoparticles
- Transposons
- Plasmids
-
Genetic Editing
- TALEN
- CRISPR/Cas9
- Zinc-finger Nucleases
- Other Systems
Why ProtaGene?
We collaborate with you to design a program customized for your molecule and the demands of your development timeline.
- Unique development expertise in both protein and gene analytics
- Broad single-vendor analytical offering from discovery to market
- Significant scale of expertise & multi-region facility presence
- Best-in-class quality, supporting robust regulatory packages
- Reputation and delivery trusted by leading biopharma companies
- Uniting scientific excellence and compliance to assist your ATMP development
Subscribe to Our Email List
Talk to Our Experts
Leading cell and gene therapy companies around the world trust ProtaGene’s analytical excellence, deep experience, and quality systems to accelerate and de-risk their therapeutic development programs.
Contact Us